Navigation Links
'Difficult-to-treat asthma' may be due to difficult-to-treat patients
Date:10/22/2009

adherence only became apparent using a combination of surrogate and objective measures," said Dr. Heaney. "Of these patients who were referred for assessment and treatment of difficult asthma, many are actually not taking their treatment as prescribed, which would suggest an important first course of action in assessing difficult asthma may actually be verifying the patient's adherence to his or her treatment protocol. Determining whether the patient is taking medications as prescribed is of utmost importance before moving to more aggressive and expensive treatments. It is also crucially important in understanding true refractory disease and assessing responses to novel therapies, either in clinical trials or clinical practice."

Some patient characteristics were more strongly associated with nonadherence than others: women were less likely to be adherent than men, a finding that had been previously identified, but that Dr. Heaney cites as needing more investigation.

Another red flag may be a lower score on quality of life measures. Dr. Heaney and colleagues found that patients who filled fewer than half of their prescribed ICT scored significantly lower on the EuroQol and the Asthma Quality of Life Questionnaire. Furthermore, the number of prior hospital admissions within the past 12 months was significantly associated with non-adherence.

"In general, one might expect in more severe disease that a very poor asthma quality of life score suggesting high morbidity, would perhaps, result in better adherence, " said Dr. Heaney. "The same could be said for hospital admission, but the reasons for non-adherence are complex. However for clinicians, multiple hospital admissions should definitely flag probable non-adherence in difficult-to-treat cases."

"Non-adherence is a common problem, which is often hard to detect. In general, asking the patient or relying on clinical impression is useless, and objective or good surrogate measures shou
'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-305-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. For Erectile Dysfunction, Physicians Indicate That Opportunity Exists for Emerging Therapies with Improved Efficacy in Difficult-to-Treat Patient Subpopulations
2. Austin, Texas, Physicians Second in Nation to Perform New Procedure for Difficult-to-Treat Atrial Fibrillation Cases
3. Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma
4. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
5. Pediatricians put proven treatment strategies to work against childhood asthma
6. Parenting Expert and Family Advocate Jo Frost and Allergy & Asthma Network Mothers of Asthmatics (AANMA) Launch Time 2 Talk Asthma
7. Rising Heat, Humidity Raise Risk of Asthma Flares
8. $450,000 Awarded for Innovative Asthma Research Into Death by Drowning in Mucus
9. Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options
10. Chlorine in Pools Raises Kids Asthma, Allergy Risk
11. Day Care May Not Shield Kids From Asthma, Allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
(Date:11/27/2014)... 27, 2014 This is a ... Insulin industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry covers information on policy, plans for ... structure and much more. , This ...
(Date:11/27/2014)... At The Little Gym, we know that ... no surprise when a recent study confirmed that regular ... Journal of Pediatrics found that “Promoting physical ... the school years may be important not only for ... monitored two groups of children; those that were engaging ...
(Date:11/27/2014)... November 27, 2014 The Emerald Cup ... Up-Close Look At This Year’s Entries | SKUNK Magazine ... Stay For Two At Their Resort, Pure Garden, In ... or L.A.-based Hempcon, The Emerald Cup is presented by ... draws much of California’s original cannabis industry." – SFGate, ...
(Date:11/27/2014)... 27, 2014 In addition to a ... important gift home this holiday season and become educated ... Visiting with relatives over the holidays may raise questions ... Although some change in cognitive ability can occur with ... normal aging. Recognizing the difference between normal aging and ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... mid-October, ahead of vaccine delivery , THURSDAY, Sept. 10 (HealthDay ... flu outbreak is expected in October, but a planned vaccine ... suggests. , The first batch of the new H1N1 vaccine, ... according to the U.S. Centers for Disease Control and Prevention. ...
... Boston Scientific Corporation (NYSE: BSX ) is scheduled to ... , Ray Elliott, President and Chief Executive Officer ... participate in a 35-minute discussion about the Company on Tuesday, September ... , A live webcast of this discussion will be ...
... ... reconstruction, quicker recovery and more natural knee motion post-surgery , ... Evanston, Illinois (Vocus) -- NorthShore University ... use a new and innovative robotic technology for minimally-invasive partial knee replacement ...
... , , WOODCLIFF ... today announced that it has received final approval from the U.S. ... nateglinide tablets. Nateglinide is a generic version of Novartis, Starlix(R). ... to IMS Health data. Par will begin shipping the 60mg ...
... , , WARSAW, Ind., ... leading independent provider of products to the global orthopedic device industry and ... Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial ... at the Grand Hyatt Grand Central Hotel in New York City on ...
... , , NEW DELHI, Sept. 10 ... in India -- today announced an inspiring list of speakers for the ... theme of TEDIndia is "The Future Beckons." , , ... from diverse disciplines. Doctor and researcher Hans Rosling will share ...
Cached Medicine News:Health News:Swine Flu Shots May Come Too Late to Stem Fall Outbreak: Study 2Health News:Swine Flu Shots May Come Too Late to Stem Fall Outbreak: Study 3Health News:Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference 2Health News:NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 2Health News:NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 3Health News:NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 4Health News:Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R) 2Health News:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 2Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 3Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 4Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 5Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 6
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
(Date:11/26/2014)... , Nov. 25, 2014 ... focused on the development of mobile diagnostic ... testing in hospital and pre-hospital settings, today ... (ISO) 13485:2003 certification.  The certification was awarded ... of the world,s leading certification bodies. ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... is equipped with a new 1/2" Progressive ... excellent sensitivity (1280 (H) x 960 (V) ... uncompressed, high-resolution, digital color images and features ... an exposure range from 1/100,000 to 17.5 ...
... DP70 brings you the latest in imaging technology ... The DP70 offers high resolution, high sensitivity, and ... demanding applications, including fluorescence. CCD ... Bit Depth - 36-bit ...
4 megapixel zoom digicam with a 4x optical zoom, Effective pixels:4.0 million CCD:1/1.8-in. type (4.13 million total pixels), Max Image size:2272 (2,272 x 1,704 pixels), Lens:4x Zoom-Nikkor; f = 7.85...
... superb stand-alone digital camera with networking capability ... or remote locations. Image acquisition and camera ... operates independently or attaches directly to a ... to capture and transfer images. Sharing images ...
Medicine Products: